Why most people quit GLP-1 within a year, and what helps

Here is the part the ads never mention: most people who start a GLP-1 medication like Ozempic or Wegovy are no longer taking it a year later. The drug only works while it is in your system, so staying on it is not a footnote to the weight loss. It is the whole game.

The short answer

Most people stop GLP-1 medications within 12 months, and in some countries far sooner. The leading reason is not a lack of willpower. It is GI side effects, followed by cost and thin support. Because weight returns once you stop, the habits that keep you on the drug and protect your muscle matter as much as the decision to start.

How many people actually stay on GLP-1 medications?

Fewer than you would guess, and the number swings wildly by country. A 2026 narrative review in Nutrients by Dziewierz and Siudak pulled together real-world persistence data from national registries and insurance claims, and the spread is striking.

Persistence here means still filling the prescription after a set time. Here is where different countries stood at the 12-month mark.

The picture gets starker over time. In the United Kingdom, persistence fell from about 55% at 12 months to roughly 35% at 24 months. In a United States obesity group tracked by Prime Therapeutics, only 8.1% were still on their GLP-1 at three years. And many people quit before they ever really start: in United States claims data, about 15% of approved prescriptions were abandoned at the pharmacy counter without a single fill, and 36% of patients stopped right after their first fill.

Why do most people stop taking GLP-1 medications?

The review sorts the reasons into three groups, and only one of them is really about the medicine itself. The other two are money and support, which is worth knowing, because two of the three are things you can plan around before they force your hand.

GI side effects are the number one reason

Nausea leads by a wide margin. When patients were asked why they quit, 64.4% pointed to nausea and 45.4% to vomiting. Across trials, GI side effects hit roughly 61% of people on a standard 2.4 mg semaglutide dose, and about 71% at the higher 7.2 mg dose tested in the STEP UP trial. These effects cluster in the first weeks, during dose escalation, which is exactly when people give up before any benefit shows.

This is the most fixable barrier. Which drug you take, semaglutide or tirzepatide, and how fast you titrate both change how rough the ramp-up feels, since some GLP-1s cause more digestive side effects than others. There is also a lot you can do to manage side effects without stopping the drug. Nausea that feels like a wall in week three is often manageable with slower dosing, smaller meals, and a frank talk with your prescriber.

Cost is the barrier you can least control

Money decides more of this than most people admit. In the United States, semaglutide for obesity runs about USD 1,349 a month, roughly four times the USD 328 price in Germany. The review found a clear dose-response between what people pay out of pocket and whether they stay on treatment. Even in Denmark, where coverage is universal, people in the lowest income group were 36% more likely to quit within a year than those in the highest.

Where the drug is unsubsidized, persistence collapses. In Poland, at EUR 200 to 250 a month, 93.4% of patients had stopped within 12 months. If cost is your pressure point, it helps to understand your coverage options and whether the drug is worth the price for your situation before you start, not after month two.

Why quitting early is its own problem

Stopping is not a neutral reset. GLP-1 medications work by acting on appetite and fullness, and when the drug leaves your system, appetite comes back. Most people regain a meaningful share of the weight, which is why what happens when you stop is a question worth asking before you begin.

There is a second cost that is easy to miss. Some of the weight you lose is muscle, not fat, with research putting lean tissue at roughly a quarter to a third of total weight lost. When you regain weight after stopping, it comes back mostly as fat, not the muscle you gave up. Quitting in month two can leave you having paid for the worst of the side effects, kept none of the benefit, and traded away a little muscle for nothing.

What actually helps you stay on a GLP-1?

The review's central argument is that persistence is not only a matter of grit. Structured nutrition and lifestyle support, the kind a registered dietitian provides, lines up with better staying power and protects the muscle you would otherwise lose. The authors are careful to note that most of these targets are borrowed from related fields rather than proven in GLP-1-specific trials, so treat them as sensible defaults, not settled law.

A few concrete moves carry most of the weight.

1. Eat enough protein. Aim for about 1.2 to 1.5 grams per kilogram of body weight, up to roughly 1.6 during rapid loss, and spread it as 25 to 30 grams across three or four meals so your body can actually use it.
2. Do resistance training two to three times a week. Nothing preserves muscle during fast weight loss as reliably as loading it, and holding on to muscle is a big part of who keeps the weight off.
3. Eat smaller, more often. Five or six smaller, nutrient-dense meals ease the gastric fullness that drives nausea, and cutting the fat load per meal during titration helps too. On a bad nausea day, liquids and semi-solid foods go down easier.
4. Drink enough water, roughly 2.7 litres a day for women and 3.7 for men, because eating less usually means drinking less without noticing.
5. Test, do not guess, on nutrients. Get baseline and follow-up checks on vitamin B12, vitamin D, iron, calcium, and zinc, since deficiencies deepen between month 6 and 12 when intake stays low.

One honest caveat sits over all of this. The Nutrients paper is a narrative review, not a systematic one, and the authors ran no formal quality scoring. It gathers real-world numbers that were measured in different ways, so treat the country figures as a clear pattern rather than exact head-to-head comparisons.

What this means if you are starting or already on a GLP-1

Treat the first two to three months as the hard stretch to get through, not proof the drug is wrong for you. That is when side effects peak and most people quit, and it is also when a plan makes the biggest difference. Line up your prescriber, your food, and your budget before you start, so a rough week does not become the end of treatment.

No supplement keeps you on a GLP-1 or does the muscle protection that protein and training do. What a targeted supplement can do is close the nutrient gap that opens when the drug cuts your food intake, so fatigue, hair thinning, and low energy do not become the reason you stop. Closing that gap is the honest lane for GLP-1 Shield, working alongside the food, training, and medical support that keep people on treatment long enough to benefit.